Lucid Diagnostics Inc. (LUCD) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Lucid Diagnostics Inc. (LUCD) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $106.4M, listed on NASDAQ, employing roughly 72 people, carrying a beta of 1.10 to the broader market. Lucid Diagnostics Inc. Led by Lishan Aklog, public since 2021-10-14.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for LUCD as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →